Skip to main content
BLFS
NASDAQ Industrial Applications And Services

Casdin Partners Confirms $28.1M Stock Sale, Reduces Stake to 9.7%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$23.95
Mkt Cap
$1.17B
52W Low
$17.86
52W High
$29.62
52W Position info
34% above low
Off High info
19% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

BLFS sits 34% above its 52-week low of $17.86 on elevated volume (2.0× avg).

Summary

Major institutional investor Casdin Partners confirmed the sale of $28.1 million worth of BioLife Solutions stock, reducing its stake to 9.7% after previously signaling intent to sell.


Key Events · Ownership and Investor Activity · BLFS

  • Significant Stake Reduction Confirmed

    Casdin Partners, a major institutional investor, reported the sale of 1,200,000 shares of BioLife Solutions common stock.

  • $28.1 Million in Sales Executed

    The shares were sold in multiple transactions between May 19-21, 2026, for a total value of approximately $28.1 million.

  • Ownership Reduced to 9.7%

    Following these sales, Casdin Partners' beneficial ownership in BioLife Solutions has decreased to 9.7% of the outstanding shares.

  • Follows Prior Intent to Sell

    This Schedule 13D/A confirms the execution of sales previously indicated by multiple Form 144 filings from Casdin Partners in the days leading up to this report.


Analysis · BLFS · Industrial Applications And Services

Casdin Partners, a significant institutional investor, has reported the sale of 1.2 million shares of BioLife Solutions common stock for approximately $28.1 million. This transaction, which reduces their beneficial ownership to 9.7%, confirms the execution of sales previously indicated by a series of Form 144 filings. The substantial reduction in their position, representing over 20% of their prior holdings, signals a significant change in their investment strategy.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BLFS was trading at $23.95 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $17.86 to $29.62. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BLFS - Latest Insights

BLFS
Oct 06, 2026, 9:11 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $39.00
Real-time Price: $39.00 info
Change: $0 (0%) info
Market Cap: $1.889B info
BLFS
Sep 30, 2026, 6:01 AM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $39.33
Real-time Price: $39.00 info
Change: -$0.330 (-0.84%) info
Market Cap: $1.889B info
BLFS
Sep 30, 2026, 6:01 AM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $39.33
Real-time Price: $39.00 info
Change: -$0.330 (-0.84%) info
Market Cap: $1.889B info
BLFS
Sep 09, 2026, 5:22 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $34.93
Real-time Price: $39.00 info
Change: +$4.07 (+12%) info
Market Cap: $1.889B info
BLFS
Sep 09, 2026, 5:21 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $34.93
Real-time Price: $39.00 info
Change: +$4.07 (+12%) info
Market Cap: $1.889B info